Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-010509)

Filing Details

Accession Number:: 0001209191-23-010509
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-02-17 16:07:57
Reporting Period:: 2023-02-15

Accepted Time:: 2023-02-17 16:07:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1503802	Karyopharm Therapeutics Inc.	KPTI	Pharmaceutical Preparations (2834)	263931704

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1942597	Stuart Poulton	C/O Karyopharm Therapeutics Inc. 85 Wells Avenue Newton MA 02459	Evp, Chief Development Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-02-15	5,665	$3.19	64,335	No	4	S	Direct
Common Stock	Disposition	2023-02-15	8	$3.23	64,327	No	4	S	Direct
Common Stock	Disposition	2023-02-15	196	$3.16	64,131	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.